U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Sugar base surfactant for nanocrystals

Patent 5622938 Issued on April 22, 1997. Estimated Expiration Date: Icon_subject May 19, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Injectable compositions, nanoparticles useful therein, and process of manufacturing same
Patent #: 4107288
Issued on: 08/15/1978
Inventor: Oppenheim ,   et al.

Process for the preparation of activated pharmaceutical compositions
Patent #: 4540602
Issued on: 09/10/1985
Inventor: Motoyama ,   et al.

5118528

Surface modified drug nanoparticles
Patent #: 5145684
Issued on: 09/08/1992
Inventor: Liversidge, et al.

Amphiphilic compounds containing two sugar or sugar-derived head groups Patent #: 5403922
Issued on: 04/04/1995
Inventor: Garelli-Calvet, et al.

Inventor

Application

No. 444796 filed on 05/19/1995

US Classes:

514/35, Oxygen of the saccharide radical bonded directly to a cyclohexyl ring424/1.29, Coated, impregnated, or colloidal particulate (e.g., microcapsule, micro-sphere, micro-aggregate, macro-aggregate)424/9.45, Halogenated benzene ring containing424/490, Coated (e.g., microcapsules)424/493, Containing polysaccharides (e.g., sugars)424/499, Contains proteins or derivative or polysaccharides or derivative510/470Carbohydrate

Examiners

Primary: Nutter, Nathan M.

Attorney, Agent or Firm

International Classes

A01N 043/04
A61K 031/70

Abstract

Dispersible particles consisting essentially of a crystalline drug substance having a surface modifier having the formula: ##STR1## wherein R is phenyl-(CH2)10 CO or C12 H25 NHCO adsorbed on the surface thereof in an amount sufficient to maintain an effective average particle size of less than about 400 nm, methods for the preparation of such particles and dispersions containing the particles. Pharmaceutical compositions containing the particles exhibit unexpected bioavailability and are useful in methods of treating mammals.

Other References

  • Lachman, et al., The Theory and Practice of Industrial Pharmacy, Chapter 2, "Milling", p. 45, (1986
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?